While the frequency of IgG reactive against TSPYL2 was similar across groups (Figure 4C), both ME/CFS cohorts exhibited higher autoantibodies levels compared to HCs (Figure 4A). The gene discussed is TSPYL2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.